| (HKD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 4.02B | — |
| Operating expense | — | — |
| Net income | 414.83M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 3759.HK returned +44.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +60.1% |
| 1 year | +44.4% |
| 5 years | -56.5% |
| All-time high | $92.00 (Jun 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in 3759.HK would be worth today ›Yes. Pharmaron Beijing Co., Ltd. paid 1 dividend over the past 12 months. The most recent was $0.23 per share on Jul 7, 2026. The dividend yield is 0.69%.
Pharmaron Beijing Co., Ltd. is part of the Healthcare sector.
Pharmaron Beijing Co., Ltd. has a market cap of 56.88B HKD, based on the latest quote.
Pharmaron Beijing Co., Ltd. is expected to report earnings around Oct 27, 2026. That date is an estimate and has not been confirmed by the company.
